Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Bueren, J.J.L. van

Refine Results

Resource Type

Availability

Creation Date

Faculty

Collection

Author

Language

Search results

  • RSS Feed
(1 - 3 of 3)
Duobody-CD3xCD20 Shows Unique and Potent Preclinical Anti-Tumor Activity in Vitro and In Vivo, and Is Being Evaluated Clinically in Patients with B-Cell Malignancies
Hiemstra, I.H.; Engelberts, P.J.; Jong, B. de; Schuurhuis, D.H.; Salcedo, T.W.; Verploegen, S.; ... ; Breij, E.C.W. 2018
Duobody-CD3xCD20 Shows Unique and Potent Preclinical Anti-Tumor Activity in Vitro and In Vivo, and Is Being Evaluated Clinically in Patients with B-Cell Malignancies
Other
metadata only
When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy
Oostendorp, M.; Bueren, J.J.L. van; Doshi, P.; Khan, I.; Ahmadi, T.; Parren, P.W.H.I.; ... ; Vooght, K.M.K. de 2015
When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy
Article / Letter to editor
metadata only
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
Overdijk, M.B.; Verploegen, S.; Bogels, M.; Egmond, M. van; Bueren, J.J.L. van; Mutis, T.; ... ; Parren, P.W.H.I. 2015
Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
Article / Letter to editor
metadata only